Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide;Parciální regrese ložisek Erdheimovy-Chesterovy nemoci v CNS po léčbě 2-chlorodeoxyadenosinem a jejich kompletní vymizení při léčbě lenalidomidem

Klinicka Onkologie

Volumn 24, Issue 5, 2011, Pages 367-381

  Adam, Zdeněk ^a   Sprlakova A ^a   Rehak Z ^b   Koukalova R ^b   Szturz, P ^a   Krejci M ^a   Pour, L ^a   Zahradova L ^a   Cervinek L ^a   Kren L ^c   Moulis, M ^a   Hermanova M ^c   Mechl, M ^a   Prasek J ^d   Hajek R ^a   Kral Z ^a   Mayer, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b Masaryk v Onkologický Ústav   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d Klinika radiologie a nukleární medicíny FN Brno   (Czech Republic)

Author keywords

2 chlorodeoxyadenosine cladribin; Erdheim Chester disease; Juvenile xanthogranuloma; Lenalidomide; Osteosclerosis; PET CT; Retroperitoneal fibrosis; Skeletal scinigraphy

Indexed keywords

CLADRIBINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUORODEOXYGLUCOSE; LENALIDOMIDE;

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETES INSIPIDUS; DRUG TOLERANCE; ERDHEIM CHESTER DISEASE; HISTOLOGY; HUMAN; HYPEROSTOSIS; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; TREATMENT RESPONSE;

ADULT; BONE MARROW; BRAIN; CLADRIBINE; ERDHEIM-CHESTER DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RADIOGRAPHY, ABDOMINAL; REMISSION INDUCTION; THALIDOMIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80155130609     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Article

References (136)

1. Sverdlow SH, Campo E, Harris NL et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press 2008.
2. Dickson BC, Pethe V, Chung CT et al. Systemic Erdheim-Chester disease Virchows Arch 2008, 452(2): 221-227.
3. Lachenal F, Cotton F, Desmurs-Clavel H et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol 2006; 253(10):1267-1277. (Pubitemid 44691550)
4. Kinkor Z, Koudela K Jr, Koudela K et al. Warfarinem vyvolaná hemoragická pseudocysta malé pánve u ženy s vrozeným genetickým defektem koagulace komplikovaná usuračním pseudoxantomem pánevní kosti napodobujícím Erdheim-Chesterovu nemoc. Acta Chir Orthop Traum Čech 2007; 74(2): 114-117.
5. Kinkor Z. Severe pulmonary involvement in Erdheim-Chester disease (case report). Cesk Patol 2001; 37(3):114-117.
6. Kinkror Z. Závažné plicní postižení u Erdheim-Chesterovy nemoci. Čs Patol 2001; 37/46(3): 114-117.
7. Kolář J, Kučera V, Povýšil C et al. Erdheim-Chester disease. Rofo 1984; 141 (6): 698-701.
8. Mergancová J, Kubes L, Elleder M. Xanthogranulomatous processes in the area of the large vessels. Cesk Patol 1986; 22(3): 145-150.
9. Mergancová J, Kubeš L, Elleder M. A xanthogranulomatous process encircling large blood vessels (Erdheim-Chester disease). Czech Med 1988; 11(1): 57-64. (Pubitemid 18095540)
10. Kučera V, Čáp V, Kužel J et al. Vzácná příčina osteosklerózy: Erdheimův-Chesterův syndrom. ČS Radiol 1984; 38(6): 393-402.
11. Janková H, Říhová E. Juvenilní xanthogranulom. Oftalmologie 2007; 3: 214-218.
12. Vašáková M. Co je to Erdheimova nemoc? Kazuist Alergol Pneumol ORL 2006; 3(4) 22-25.
13. Mottl H, Koutecký J, Ganevová M. Strategie léčby histiocytózy z Langerhansových buněk u dětí. Čes-slov Pediat 1994; 49(2): 81.
14. Mottl H, Starý J. Histiocytóza z Langerhansových buněk u děti - klinická diagnostika a souč asná léčba. Česslov Pediat 2007; 62(4): 200-225.
15. Plank L. Diagnostická patologia non-Langerhans cell histiocytóz. Vnitř Lék 2010; 56 (Suppl 2): 2S39-2S63.
16. Adam Z, Zahradová L, Krejčí M et al. Difuzní plošná normolipemická xantomatóza a nekrobiotický xantogranulom, asociované s monokloná lní gamapatií - přínos PET-CT pro stanovení rozsahu nemoci a zkušenosti s léčbou. Popis dvou případů a přehled literatury Vnitř Lék 2010; 56(11): 1158-1168.
17. Zahradová L, Adam Z, Feit J et al. Nekrobiotický xanthogranulom vzácná kožní komplikace u nemocného s mnohočetným myelomem. Vnitř Lék 2010; 56 (Suppl 2): 2S179-2S182.
18. Chester W Über lipoigranulomatóse. Virchows Arch 1930; 279: 561-602.
19. Jaffe HL. Hematologic, degenerative and inflammatory disease of bones and joints. Philadelphia, PA: Lea and Febiger 1972: 531-541.
20. Miller RL, Sheeler LR, Bauer TW et al. Erdheim-Chester disease. Case report and review of the literature. Am J Med 1986; 80(5): 1230-1236.
21. Corradi D, Maestri R, Palmisano A et al. Idiopathic retroperitoneal fibrosis: clinicopathological features and diferencial diagnosis. Kidney Int 2007; 72(6): 742-753. (Pubitemid 47373794)
22. Alper MG, Zimmerman LE, Piana FG. Orbital manifestatiton of Erdheim-Chester disease. Trans Am Ophthalmol Soc 1983; 81: 64-85.
23. Garg T, Chander R, Gupta T et al. Erdheim-Chester disease with cutaneous features in an Indian patient. Skinmed 2008; 7(2): 103-106.
24. Kenn W, Eck M, Allolio B et al. Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immonohistochemical analysis. Hum Pathol 2000; 31(6): 734-739. (Pubitemid 30445478)
25. Kenn W, Stábler A, Zachoval R et al. Erdheim-Chester disease: a case report and literature overview. Eur Radiol 1999; 9(1): 153-158.
26. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75(3):157-169. (Pubitemid 26159212)
27. Perras B, Petersen D, Lorch H et al. Psychoneuroendocrine disturbances in a patient with a rare granulomatous disease. Exp Clin Endocrinol Diabetes 2002; 110(5):248-252.
28. Brodkin CL, Wszolek ZK. Neurologic presentation of Erdheim-Chester disease. Neurol Neurochir Pol 2006;40(5): 397-403. (Pubitemid 44755964)
29. De Abreu MR, Chung CB, Biswal S et al. Erdheim-Chester disease: MR imaging, anatomic, and histopathologic correlation of orbital involvement. AJNR Am J Neuroradiol 2004; 25(4): 627-630. (Pubitemid 38541944)
30. Salsano E, Savoiardo M, Nappini S et al. Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim-Chester disease. Neurol Sci 2008; 29(4): 263-267.
31. Sistermann R, Katthagen BD. Erdheim-Chester disease: a rare cause of knee and leg pain. Arch Orthop Trauma Surg 2000; 120(1-2): 112-113. (Pubitemid 30009200)
32. Yanagi T, Kato N, Yamane N et al. Verruca plana-like papules as a new manifestation of Erdheim-Chester disease. Arch Dermatol 2007; 143(7): 952-953. (Pubitemid 47076508)
33. Sivak-Callcott JA, Rootman J, Rasmussen SL et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol 2006; 90(5): 602-608.
34. Watermann DF, Kiesewetter F, Frosch PJ. Skin manifestations of Erdheim-Chester disease. Case report and review of the literature. Hautarzt 2001; 52(6): 510-517. (Pubitemid 32510364)
35. Hammond MD, Niemi EW, Ward TP et al. Adult orbital xanthogranuloma with associated adult-onset asthma. Ophthal Plast Reconstr Surg 2004; 20(4): 329-332. (Pubitemid 38971793)
36. Karcioglu ZA, Sharara N, Boles TL et al. Orbital xanthogranuloma: clinical and morphologic features in eight patients. Ophthal Plast Reconstr Surg 2003; 19(5): 372-381. (Pubitemid 37175452)
37. Kujat C, Martin J, Püschel W. Die Erdheim-Chester Krankheit. Radiologe 1991; 31: 297-306.
38. Fink MG, Levinson DJ, Brown NL et al. Erdheim-Chester disease. Case report with autopsy finding. Arch Pathol Lab Med 1991; 115(6): 619-623.
39. Tien RD, Brasch RC Jackson DE et al. Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images. Radiology 1989; 172(3): 791-792. (Pubitemid 19211606)
40. Martinez R. Erdheim-Chester disease: MR of intraaxilal and extraaxial brein stem lesion. AJNR Am J Neuroradiol 1995; 16(9): 1787-1790.
41. Ernemann U, Skalej M, Hermisson M et al. Primary cerebral non-Langerhans cell histiocytosis: MRI and differential diagnosis. Neuroradiology 2002; 44(9): 759-763. (Pubitemid 36067860)
42. Babu RR, Lansen TA, Chadburn A et al. Erdheim-Chester disease of the central nervous system. Report of two cases. J Neurosurg 1997; 86(5): 888-892. (Pubitemid 27187695)
43. Bohlega S, Alwatban J, Tulbah A et al. Cerebral manifestation of Erdheim-Chester disease: clinical and radiologic findings. Neurology 1997; 49(6): 1702-1705. (Pubitemid 28015143)
44. Weidauer S, von Stuckrad-Barre S, Dettmann E et al. Cerebral Erdheim-Chester disease: case report and review of the literature. Neuroradiology 2003, 45(4): 241-245. (Pubitemid 36700850)
45. Wright RA, Hermann RC, Parisi JE. Neurological manifestations of Erdheim-Chester disease. J Neurol Neurosurg Psychiatry 1999; 66(1): 72-75. (Pubitemid 29101492)
46. Shimada S, Ono K, Hashizume Y et al. Intracranial lesion of Erdheim-Chester disease. Hum Pathol 2007; 38(6):950-951. (Pubitemid 46735957)
47. Grothe C, Urbach H, Bos M et al. Cerebellar syndrome, exophthalmos and secondary hypogonadism in Erdheim-Chester disease. Nervenarzt 2001; 72(6): 449-452. (Pubitemid 32530275)
48. Khamseh ME, Mollanai S, Hashemi F et al. Erdheim-Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus. J Endocrinol Invest 2002; 25(8): 727-729.
49. Kovacs K, Bilbao JM, Fornasier VL et al. Pituitary pathology in Erdheim-Chester disease Endocr Pathol 2004; 15(2): 159-166. (Pubitemid 39179427)
50. Oweity T, Scheithauer BW, Ching HS et al. Multiple system Erdheim-Chester disease with massive hypothalamic-sellar involvement and hypopituitarism. J Neurosurg 2002; 96(2): 344-351. (Pubitemid 34230251)
51. Tritos NA, Weinrib S, Kaye TB. Endocrine manifestations of Erdheim-Chester disease (a distinct form of histiocytosis). J Intern Med 1998; 244(6): 529-535. (Pubitemid 28552860)
52. Sheu SY, Wenzel RR, Kersting R et al. Erdheim-Chester disease: a case report with multisystemic manifestation including testes, thyroid, and lymph nodes and a review of literature. J Clin Pathol 2004, 57(11): 1225-1228. (Pubitemid 39486535)
53. Bullmann C, Faust M, Hoffmann E et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur J Endocrinol 2000; 142(4): 365-372. (Pubitemid 30230762)
54. Mahnel R, Tan KH, Fahlbusch R et al. Problems in differential diagnosis of non Langerhans cell histiocytosis with pituitary involvement, case report and review of literature. Endocr Pathol 2002; 13(4): 361-368. (Pubitemid 36237990)
55. Sheen KC, Chang CC, Chang TC et al. Thikened pituitary stalk with central diabetes insipidus: report of 3 cases. J Formos Med Assoc 2001; 100(3): 198-204.
56. Takao T, Asaba K Tanaka H et al. A case of of lymphocytic infundibuloneurohypophysitis schowing diabetes inspidus followed by anterior hypopituitarism associated with trombnasthenia. Endocr J 2000; 47(3): 285-291.
57. Tashiro T, Sano T, Xu B et al. Spectrum of different types of hypophysitis: a clinicopathologic study hypophysitis in 31 cases. Endocr Pathol 2002; 13(3): 183-185.
58. Mohn A, Fahlbusch R, Dörr HG. Panhypopituitarism associated with diabetes insipidus in a girl with a suprasellar arachnoid cyst. Horm Res 1999; 52(1): 35-38. (Pubitemid 30071927)
59. Folkerth RD, Price DL Jr, Schwartz M et al. Xanthomatous hypophysitis. Am J Surg Pathol 1998; 22(6): 736-741. (Pubitemid 28280276)
60. Athanasou NA, Barbatis C. Erdheim-Chester disease with epiphyseal and systemic disease. J Clin Pathol 1993; 46(5): 481-482. (Pubitemid 23167432)
61. Augoustides JG, Szeto WY. Unmasked diabetes insipidus after pericardial drainage and biopsy for pericardial effusion in association with Erdheim-Chester disease. JThorac Cardiovasc Surg 2008; 136(1): 217-218.
62. Rushing EJ, Kaplan KJ, Mena H et al. Erdheim-Chester disease of the brain: cytological features and differential diagnosis of a challenging case. Diagn Cytopathol 2004; 31(6): 420-422. (Pubitemid 39578585)
63. Reithmeier T, Trost HA, Wolf S et al. Xanthogranuloma of the Erdheim-Chester type within the sellar region: case report. Clin Neuropathol 2002; 21(1): 24-28. (Pubitemid 34098165)
64. Allen TC, Chevez-Barrios P, Shetlar DJ et al. Pulmonary and ophthalmic involvement with Erdheim-Chester disease: a case report and review of the literature. Arch Pathol Lab Med 2004; 128(12): 1428-1431. (Pubitemid 39627482)
65. Kambouchner M, Colby TV, Demenge C et al. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology 1997; 30(4): 353-358. (Pubitemid 27168796)
66. Krüger S, Krop C, Wibmer T et al. Erdheim-Chester disease: a rare cause of interstitial lung disease. Med Klin (Munich) 2006; 101(7): 573-576. (Pubitemid 44098597)
67. Protopapadakis C, Antoniou KM, Nicholson AG et al. Erdheim-Chester disease: pulmonary presentation in a case with advanced systemic involvement. Respiration 2009; 77(3): 337-340.
68. Shamburek RD, Brewer HB Jr, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 2001; 321(1): 66-75.
69. Rush WL, Andriko JA, Galateau-Salle F et al. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 2000; 13(7): 747-754. (Pubitemid 30470164)
70. Vašáková M, Fiala P, Kinkor Z. Erdheim-Chester disease: a case report. Monaldi Arch Chest Dis 2001; 56(2): 115-117.
71. Vaglio A, Corradi D, Maestri R et al. Pericarditis heralding Erdheim-Chester disease. Circulation 2008; 118(14): e511-e512.
72. Serratrice J, Granel B, De Roux C et al. "Coated aorta": a new sign of Erdheim-Chester diseae. J Rheumatol 2000; 27(6): 1550-1553. (Pubitemid 30354063)
73. Haroche J, Amoura Z, Dion E et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review Medicine (Baltimore) 2004; 83(6): 371-392. (Pubitemid 39541113)
74. Bassou D, El Kharras A, Taoufik AT et al. Cardiac Erdheim-Chester. Intern Med 2009, 48(1): 83-84.
75. Dion E, Graef C, Haroche J et al. Imaging of thoracoabdominal involvement in Erdheim-Chester disease. AJR Am J Roentgenol 2004; 183(5): 1253-1260. (Pubitemid 44210586)
76. Granier M, Micheau A, Serre I. A rare cause of cardiac tumour: an Erdheim-Chester disease with cardiac involvement co-existing with an intracerebral Langerhans cell histiocytosis. Eur Heart J 2008; 29(16): 1929-1935.
77. Loeffler AG, Memoli VA. Myocardial involvement in Erdheim-Chester disease. Arch Pathol Lab Med 2004; 128(6): 682-685. (Pubitemid 41490431)
78. Kudo Y, Iguchi N, Sumiyoshi T et al. Dramatic change of Ga-67 citrate uptake before and after corticosteroid therapy in a case of cardiac histiocytosis (Erdheim-Chester disease). J Nucl Cardiol 2006; 13(6): 867-869. (Pubitemid 44890817)
79. Loddenkemper K, Hoeyr B, Loddenkemper C et al. A case of Erdheim-Chester disease initially mistaken as Ormond's diseae. Nat Clin Pract Rhematol 2008; 4(1): 50-55.
80. Bangard C, Lotz J, Rosenthal H et al. Erdheim-Chester disease versus multifocal fibrosis and Ormond's disease: a diagnostic dilemma. Clin Radiol 2004; 59(12): 1136-1141. (Pubitemid 40045629)
81. Murray M, Marshall M, England E et al. Erdheim-Chester disease. Clin Radiol 2001; 56(6): 481-484.
82. Haroche J, Amoura Z, Touraine P et al. Bilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature review. J Clin Endocrinol Metab 2007; 92(6): 2007-2012. (Pubitemid 46997091)
83. Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics 2005; 25(3): 719-730. (Pubitemid 40826791)
84. Scheer M, Hon M, Fruauff AA et al. Perinephric xanthogranulomatosis: CT diagnosis and confirmation by CT-guided percutaneous biopsy Clin Imaging 2000; 24(2): 64-67.
85. Surabhi VR, Menias C, Prasad SR et al. Neoplastic and non-neoplastic proliferative disorders of the perirenal space: cross-sectional imaging findings. Radiographics 2008; 28(4): 1005-1017.
86. Colin P, Ballereau C, Lambert M et al. Retroperitoneal infiltration as the first sign of Erdheim-Chester disease. Int J Urol 2008; 15(5): 455-456. (Pubitemid 351623885)
87. Moore FO, Berne JD, Fox AD. Mesenteric panniculitis and Erdheim-Chester disease: xanthogranulomatous diseases confused with malignancy. J Am Coll Surg 2007; 204(2): 326-327. (Pubitemid 46124034)
88. Droupy S, Attias, D, Eschwege P et al. Bilateral hydronefrosis in a patient with Erdheim-Chester disease. J Urol 1999; 162(6): 2084-2085.
89. O'Rourke R, Wong DC, Fleming S et al. Erdheim-Chester disease: a rare cause of acute renal failure. Australas Radiol 2007; 51: B48-B51. (Pubitemid 47413935)
90. Verdalles U, Goicoechea M, García de Vinuesa S et al. Erdheim-Chester disease: a rare cause of renal failure. Nephrol Dial Transplant 2007; 22(6): 1776-1777. (Pubitemid 47073785)
91. Wimpissinger TF, Schernthaner G, Feichtinger H et al. Compression of kidneys in Erdheim-Chester disease of retroperitoneum: open surgical approach. Urology 2005; 65(4): 798.
92. Gupta A, Aman K, Al-Babtain M et al. Multisystem Erdheim-Chester disease; a unique presentation with liver and axial skeletal involvement. Br J Haematol 2007; 138(3): 280. (Pubitemid 47035384)
93. Canbaz F, Dabak N, Baris S et al. Erdheim-Chester disease: 99mTc-MDP bone scan provides the diagnosis. Eur J Nucl Med Mol Imaging 2005; 32(8): 998. (Pubitemid 41205674)
94. Dion E, Graef C, Miquel A et al. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology 2006; 238(2): 632-639. (Pubitemid 43134376)
95. Girszyn N, Arnaud L, Villain D et al. Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease. Rev Med Interne 2007; 28(11): 770-774. (Pubitemid 47600437)
96. Hoffmann EM, Müller-Forell W, Pitz S et al. Erdheim-Chester diseae: a case report. Graefes Arch Clin Exp Ophthalmol 2004; 242(9): 803-807.
97. Gottlieb R, Chen A. MR findings of Erdheim-Chester disease. J Comput Assist Tomogr 2002; 26(2): 257-261. (Pubitemid 34233374)
98. Nakahara T, Suzuki T, Uno K et al. 18F-FDG positron emission tomographic imaging in Erdheim-Chester disease with skeletal and extra-skeletal involvement. Leuk Lymphoma 2006, 47(5): 935-937. (Pubitemid 43840656)
99. Namwongprom S, Núñez R, Kim EE et al. Tc-99m MDP bone scintigraphy and positron emission tomography/computed tomography (PET/CT) imaging in Erdheim-Chester disease. Clin Nucl Med 2007; 32(1): 35-38. (Pubitemid 46360591)
100. Blum R, Seymour JF, Hicks RJ. Role of 18FDG-positron emission tomography scanning in the management of histiocytosis. Leuk Lymphoma 2002; 43(11) 2155-2157. (Pubitemid 35174729)
101. Palotás A, Bogáts G, Lázár M et al. Radiopharmaceutical diagnosis of Erdheim-Chester's disease. Nucl Med Commun 2007; 28(1): 63-65. (Pubitemid 44949690)
102. Spyridonidis TJ, Giannakenas C, Barla P et al. Erdheim-Chester disease: a rare syndrome with a characteristic bone scintigraphy pattern. Ann Nucl Med 2008; 22(4): 323-326. (Pubitemid 351809789)
103. Zanglis A, Valsamaki P, Fountos G. Erdheim-Chester disease: symmetric uptake in the (99m)Tc-MDP bone scan. Hell J Nucl Med 2008; 11(3): 164-167.
104. Kim EE. Romero JA. Erdheim-Chester disease demonstrated with bone radiograph and scans. Clin Imaging 1997;21(5): 328-331. (Pubitemid 27466616)
105. Koziolek MJ, Kunze E, Müller A et al. Erdheim-Chester disease. Dtsch Med Wochenschr 2005; 130(1-2): 25-28. (Pubitemid 40093257)
106. Arnaud L, Malek Z, Archambaud F et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 2009, 60(10): 3128-3138.
107. Matsui K, Nagata Y, Hiraoka M. Radiotherapy for Erdheim-Chester disease. Int J Clin Oncol 2007; 12(3): 238-241. (Pubitemid 46944634)
108. Perlat A, Decaux O, Sébillot M et al. Erdheim-Chester disease with predominant mesenteric localization: lack of efficacy of interferon alpha. Joint Bone Spine 2009, 76(3): 315-317.
109. Vanichaniramol N, Kingpetch K, Buranasupkajorn P et al. Erdheim-Chester disease. Intern Med 2008; 47(18): 1633-1634.
110. Ono K, Oshiro M, Uemura K et al. Erdheim-Chester disease: case report with imunohistochemical and biochemical examination. Hum Pathol 1996; 27(1): 91-95. (Pubitemid 26015588)
111. Egan AJ, Boardman LA, Swensen SJ et al. Erdheim-Chester disease: clinical, radiologic and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999; 23(1): 17-26. (Pubitemid 29025237)
112. Kim NR, Ko YH, Choe YH et al. Erdheim-Chester disease with extensive marrow necrosis: a case report and literature review. Intern J Surg Pathol 2001; 9(1): 73-79. (Pubitemid 32295130)
113. Busemann C, Kallinich B, Schwesinger G et al. Erdheim-Chester disease with hemophagocytosis. Ann Hematol 2007; 86(11): 847-849.
114. Rao RN, Chang CC, Uysal N et al. Fulminant multisystem non-langerhans cell histiocytic proliferation with hemophagocytosis: a variant form of Erdheim-Chester disease. Arch Pathol Lab Med 2005; 129(2) e39-e43.
115. Lopez P, Estes ML. lmmunohistochemical characterization of the histiocytes in sinus histiocytosis with massive lymphadenopathy: analysis of an extraosseal case. Hum Pathol 1989; 20(7): 711-715. (Pubitemid 19185304)
116. Bonetti F, Chilosi M, Menestrina F et al. Immunohistochemical analysis of Rosai-Dorfman histiocytosis. A disease of S-100 + CD1-histiocytes. Virchows Arch A Pathol Anat Histopathol 1987, 411(2): 129-135. (Pubitemid 17081643)
117. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity Semin Diagn Pathol 1990; 7(1): 19-73. (Pubitemid 20075700)
118. Braiteh F, Boxrud C, Esmaeli B et al. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood 2005; 106(9): 2992-2994. (Pubitemid 41565890)
119. Bourke SC, Nicholson AG, Gibson GJ. Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax 2003; 58(11): 1004-1005. (Pubitemid 37392815)
120. Haroche J, Amoura Z, Trad SG et al. Variability in the efficacy of interferon alpha in Erdheim-Chester disease by patient and site of involfement: results in eight patients. Arthritis Rheum 2006; 54(10): 3330-3336. (Pubitemid 44622105)
121. Esmaeli B, Ahmadi A, Tang R et al. Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. Am J Ophthalmol 2001; 132(6): 945-947. (Pubitemid 33122188)
122. Myra C, Sloper L, Tighe PJ et al. Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 2004; 88(6): 844-847. (Pubitemid 38725610)
123. Sheidow TG, Nicolle DA, Heathcote JG. Erdheim-Chester disease: two cases of orbital involvement. Eye (Lond) 2000; 14(4): 606-612.
124. Rajendra B, Duncan A, Parslew R et al. Successful treatment of central nervous system juvenila xanthogranulomatous with cladribine. Pediatr Blood Cancer 2009; 52(3): 423-415.
125. Jendro MC, Zeidler H, Rosenthal H et al. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 2004; 23(1): 52-56. (Pubitemid 38247974)
126. Mascalchi M, Nencini P, Nistri M et al. Failure of radiation therapy for brain involvement in Erdheim-Chester disease. J Neurooncol 2002; 59(2): 169-172. (Pubitemid 35021566)
127. Miller RC, Villa S, Kamer S et al. Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study. Radiother Oncol 2006; 80(3): 323-326. (Pubitemid 44419430)
128. Haroche J, Amoura Z, Charlotte F et al. Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis. Blood 2008; 111(11): 5413-5415.
129. Janku F, Amin HM, Yang D et al. Response of histiocytoses to imatinib mesylate: fire to ashes. J Clin Oncol 2010; 28(31): e633-e636.
130. Boissel N, Wechsler B, Leblond V Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001, 135(9): 844-845. (Pubitemid 33051276)
131. Silapunt S, Chon SY. Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide. J Drugs Dermatol 2010; 9(3): 273-276.
132. Aouba A, Georgin-Lavialle S, Pagnoux C et al. Rationale for efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 2010; 116(20): 4070-4076.
133. Srikulmontree T, Massey HD, Roberts WN Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action. Rheumatol Int 2007; 27(3): 303-307. (Pubitemid 46088264)
134. Eyigör S, Kirazli Y, Memis A et al. Erdheim-Chester disease: the effect of bisphosphonate treatment a case report. Arch Phys Med Rehabil 2005; 86(5): 1053-1057. (Pubitemid 40692378)
135. Mossetti G, Rendina D, Numis FG et al. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol 2003; 21(2): 232-236. (Pubitemid 36519571)
136. Tan IB, Padhy AK, Thng CH et al. Intensely hypermetabolic extra-axial brainstem tumor in Erdheim-Chester disease. Clin Nucl Med 2009; 34(9): 604-607.